Antioxidant potential of melatonin enhances the response to L-dopa in 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine-parkinsonian mice. (Q46552275)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24399717%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

Antioxidant potential of melatonin enhances the response to L-dopa in 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine-parkinsonian mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24399717%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

0 references

1 reference

Sawsan Abo-Bakr Zaitone

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24399717%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Lamiaa N Hammad

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24399717%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Noha E Farag

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24399717%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

publication date

1 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24399717%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

published in

Pharmacological Reports

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24399717%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24399717%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24399717%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

1213-1226

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24399717%20AND%20SRC:MED&resulttype=core&format=json

Vitamins in human arteriosclerosis with emphasis on vitamin C and vitamin E.

4 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Mitochondrial regulation by melatonin and its metabolites.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

1 reference

7 January 2021

No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

L-dopa cytotoxicity to PC12 cells in culture is via its autoxidation.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

The selective alpha1 adrenoceptor antagonist HEAT reduces L-DOPA-induced dyskinesia in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

DNA oxidatively damaged by chromium(III) and H(2)O(2) is protected by the antioxidants melatonin, N(1)-acetyl-N(2)-formyl-5-methoxykynuramine, resveratrol and uric acid

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

The neuroprotective effect of melatonin against the induction of c-Jun phosphorylation by 6-hydroxydopamine on SK-N-SH cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Oxidative stress and antioxidant therapy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutathione in the extrapyramidal system of the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Novel aspects of dopamine oxidative metabolism (confounding outcomes take place of certainties).

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Neuroprotection by melatonin from kainate-induced excitotoxicity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Serum cholesterol and lipid peroxidation are decreased by melatonin in diet-induced hypercholesterolemic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson's disease: relationship to clinical data

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Melatonin inhibits amphetamine-induced increase in alpha-synuclein and decrease in phosphorylated tyrosine hydroxylase in SK-N-SH cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Distinct mechanisms of neurodegeneration induced by chronic complex I inhibition in dopaminergic and non-dopaminergic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Melatonin suppresses iron-induced neurodegeneration in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Effect of pineal indoles on activities of the antioxidant defense enzymes superoxide dismutase, catalase, and glutathione reductase, and levels of reduced and oxidized glutathione in rat tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Metabolism of melatonin by human cytochromes p450.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Peripheral markers of oxidative stress in Parkinson's disease. The role of L-DOPA.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Melatonin regulation of antioxidant enzyme gene expression.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Axonal plasticity and functional recovery after spinal cord injury in mice deficient in both glial fibrillary acidic protein and vimentin genes

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Inhibition of proteasome activity sensitizes dopamine neurons to protein alterations and oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by L-3,4-dihydroxyphenylalanine (L-DOPA) and dopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Rotenone induces cell death in primary dopaminergic culture by increasing ROS production and inhibiting mitochondrial respiration.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Melatonin and reproduction revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Antioxidant properties of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Endogenous melatonin protects L-DOPA from autoxidation in the striatal extracellular compartment of the freely moving rat: potential implication for long-term L-DOPA therapy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Uptake and binding of dopamine and 6-hydroxydopamine in murine neuroblastoma and fibroblast cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Role of melatonin in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Melatonin protects against clomiphene citrate-induced generation of hydrogen peroxide and morphological apoptotic changes in rat eggs.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

Acetyl-L-carnitine and α-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971479-8

7 January 2021

10.1016/S1734-1140(13)71479-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24399717%20AND%20SRC:MED&resulttype=core&format=json

release_cmnxysf675ar3bidbsrbuttmbi

4 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cmnxysf675ar3bidbsrbuttmbi

24 November 2022

mapped directly with Wikidata item

1 reference